Dr. Paul Sorajja is an interventional cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, where he is the Director of the Center for Valve and Structural Heart Disease, and is the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation. He received his medical degree from Mayo Medical School, and completed his Internal Medicine Residency and Cardiology Fellowship at the Mayo Graduate School of Medicine. During 1998-99, he was a clinical research fellow in myopathy at St. George’s Hospital in London, UK. Dr. Sorajja joined the Mayo Clinic staff in 2006, achieving the rank of Professor of Medicine in 2012. In 2013, Dr. Sorajja joined the Minneapolis Heart Institute. Dr. Sorajja’s clinical practice specializes in interventional cardiology, with a focus on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the first transcatheter mitral valve replacement in the U.S. for a patient with native mitral regurgitation in 2015, and has the highest worldwide experience with TMVR.
Dr. Sorajja has published over 200 manuscripts and book chapters, with expertise in cardiac hemodynamics, clinical education, hypertrophic cardiomyopathy, and percutaneous therapy of structural heart disease. He has served in leadership positions in multiple national societies, and is a founding Board member of the Cardiovascular Innovations Foundation (cvinnovations.org<http://cvinnovations.org). Dr. Sorajja has been an editor-in-chief for numerous textbooks on cardiac catheterization. He has served as a program director for interventional cardiology fellowships, and has received awards for his expertise in medical education. In 2017, he received the Robert G. Hauser Award for Leadership Excellence in Innovation from the Minneapolis Heart Institute Foundation. Dr. Sorajja is also highly active in intellectual property development.